Quanterix corp QTRX.US 總覽分析
)QTRX 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分優異，但股利評分未超過2分，若公司開始配息，可能會有更優異的投資結果
QTRX 近期報酬表現
-3.41%
Quanterix corp
1.99%
同產業平均
-0.64%
S&P500
與 QTRX 同產業的標的表現
- CBLL Ceribell inc價值 -趨勢 1 分波段 2 分籌碼 3 分股利 1 分查看更多
QTRX 公司資訊
Quanterix Corporation is a life sciences company. The Company develops and commercializes ultra-sensitive digital immunoassay platforms that advance life sciences research and diagnostics. Its platforms are based on its proprietary digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, Nova Beads, and neurofilament light chain (NfL) antibodies and NfL ELISA kits. It also offers contract research services for customers and laboratory developed test services through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development.